Paul Edward Kelly - 16 May 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Operating Officer, Director
Signature
/s/ Paul Kelly
Issuer symbol
RLMD
Transactions as of
16 May 2025
Net transactions value
+$86,060
Form type
4
Filing time
20 May 2025, 18:03:44 UTC
Previous filing
11 Sep 2024
Next filing
30 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Paul Edward Chief Operating Officer, Director C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, /s/ Paul Kelly 20 May 2025 0001658544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $86,060 +200,000 +94% $0.4303 412,295 16 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2 Purchase prices range from $0.4071 to $0.4498 per share, inclusive.